• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 10th November 2020

Virtual ISPOR European 2020

The Virtual ISPOR Europe 2020 will be commencing next week. A number of OHE researchers will be in attendance to present their research. With the theme Improving Health: Establishing Incentives and Sharing Value, Virtual ISPOR Europe 2020 will question the…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

The Virtual ISPOR Europe 2020 will be commencing next week. A number of OHE researchers will be in attendance to present their research.

With the theme Improving Health: Establishing Incentives and Sharing Value, Virtual ISPOR Europe 2020 will question the fundamental conventions around value, risk, rewards, and the role of public and private sectors.

The Virtual ISPOR Europe 2020 will be commencing next week. A number of OHE researchers will be in attendance to present their research.

With the theme Improving Health: Establishing Incentives and Sharing Value, Virtual ISPOR Europe 2020 will question the fundamental conventions around value, risk, rewards, and the role of public and private sectors.   

This event provides dedicated opportunities to network with peers, HEOR experts, thought leaders, and to discuss how to establish, incentivise and share values sustainable for health systems, patients, and technology developers with a global audience.

Please see below for information on presentations by OHE participants:

Friday 13th November 10, 2020

Time: 13:30 – 15:00

Note: The ISPOR Issue Panel on demand session on cost-effectiveness thresholds, value-based pricing and market allocative efficiency will be repeated to allow audience to post questions to panellists in a live Q&A session Value-Based Pricing and Market Allocative Efficiency: How Should Cost-Effectiveness Thresholds be Set to “Optimally” Distribute Value between Payers and Developers? – available to registered attendees

Mikel Berdud, PhD, MSc

Senior Principal Economist, Office of Health Economics

Panellist of ISPOR Europe Issue Panel

In the session the panel discussed the implications of setting CETs for value distribution between payers (consumers) and developers (producers). They debated how CETs should be determined and Nancy Devlin introduced the issue and moderated the panel, ensuring debate and audience participation. In this On-Demand repeated session the panellists will be live to answer questions

 

Wednesday 18th November 2020

Time: 15:00 – 16:30

Bridging the Gap- Pathways for Regulatory and Health Technology Assessment of Histology Independent Therapies

Lotte Steuten, PhD, MSc

Vice President and Head of Consulting, Office of Health Economics

Moderator 

Lotte will moderate this Educational Symposium where panellists will provide an insight into the current regulatory and HTA landscape for histology-independent therapies in various countries in North America, Europe and Asia, and discuss how to move forward from here. Global experts on histology-independent therapies will present their insights and discuss how to make a positive change from a patient representative perspective, a medical perspective and an HTA and policy perspective.

 

Pre-recorded sessions:  available now to registered attendees

Developments in HTA processes and methods

Marina Rodes Sanchez, MSc

Senior Economist, Office of Health Economics

Panellist: on demand podium session

Marina presents an in-depth analysis by the OHE on Adaptive Pathways for Tumour Agnostic Medicines in Various Developed Markets. While challenges for Tumour Agnostic medicines are similar in various countries, solutions will likely have to be diverse and include methodological advancements, novel payment models and decision-makers’ willingness to adopt new approaches. This presentation provides recommendations on each of these to further stimulate dialogue between the various stakeholders involved.

 

Pre-recorded sessions:  available now to registered attendees

A longer life or a quality death? A discrete choice experiment to estimate the relative importance of different aspects of end-of-life care

Chris Skedgel, PhD, MDE

Associate Director, Office of Health Economics

Presenter

Using discrete choice methods, Chris and his co-author find that a majority of the public prioritise good relations with family and a sense of dignity and control over survival gains at end-of-life. This may have implications for how we value end-of-life care using time-based measures such as the QALY.

 

Impact of Including Caregiver Information in Time Trade-Off Tasks: Results from a Pilot Study

David Mott, PhD, MSc

Senior Economist, Office of Health Economics

Co-Author

This poster by David Mott and co-authors presents the results of a pilot health state valuation study that explored the feasibility of investigating whether participants implicitly consider the impact of the health state on others. Two time trade-off exercises were conducted with participants, one following the traditional approach, and one that provided contextual information about the need for a carer, and the carer’s health state. The task was feasible to conduct in practice but there were no differences in average utilities due to substantial heterogeneity between participants. Further research is required to better understand this variation, and the results of this study could be useful in informing the design of such studies in future.

 

We look forward to having you join us!

 

  • Measuring and Valuing Outcomes

Related News

Group 11119
  • News
  • February 2023

Applications open for MSc Fellowship Programme 2023

Read more
Prize event
  • News
  • January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Read more
  • News
  • July 2022

OHE is Leading Research to Develop an EQ-5D ‘Bolt-on’ for Hearing

Read more
MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!